Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Local Administration of EXPAREL for Prolonged Postsurgical Analgesia in Subjects Undergoing Third Molar Extraction
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Dec 2020
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Dental pain; Postoperative pain
- Focus Pharmacokinetics; Registrational
- Sponsors Pacira Pharmaceuticals
- 02 May 2019 According to a Pacira BioSciences media release, data accepted for presentation at International Association of Dental Research Meeting 2019.
- 09 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 25 Sep 2015 Planned number of patients changed from 100 to 175, as reported by ClinicalTrials.gov.